These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2659281

  • 1. The pathology of murine myelogenous leukemias.
    Perkins AS.
    Curr Top Microbiol Immunol; 1989; 149():3-21. PubMed ID: 2659281
    [Abstract] [Full Text] [Related]

  • 2. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM, Brunetti IL, Campa A, Catalani LH, Calado RT, Falcão RP.
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [Abstract] [Full Text] [Related]

  • 3. [Clinico-cytological parallels in acute myeloid leukemia in children].
    Protasova AK, Maiakova SA, Tupitsyn NN, Rybina LN.
    Pediatriia; 1991; (11):39-43. PubMed ID: 1766738
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P.
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [Abstract] [Full Text] [Related]

  • 5. Cytochemical diagnosis of acute myelomonocytic leukemia.
    Tavassoli M, Shaklai M, Crosby WH.
    Am J Clin Pathol; 1979 Jul; 72(1):59-62. PubMed ID: 88177
    [Abstract] [Full Text] [Related]

  • 6. Quantitative enzyme determination in acute myeloid leukemia.
    Ossenkoppele GJ, Wijermans PJ, Huijgens PC, Nauta JJ, Langenhuijsen MM.
    Leuk Res; 1991 Jul; 15(6):481-6. PubMed ID: 1650411
    [Abstract] [Full Text] [Related]

  • 7. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
    Kaiserling E, Horny HP, Geerts ML, Schmid U.
    Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
    [Abstract] [Full Text] [Related]

  • 8. Monocytic leukemias.
    Shaw MT.
    Hum Pathol; 1980 May; 11(3):215-27. PubMed ID: 6995269
    [Abstract] [Full Text] [Related]

  • 9. To the incidence of nucleoli in circulating myeloblasts of patients suffering from acute myeloblastic, promyelocytic and myelomonocytic leukemias.
    Smetana K, Subrtová H, Jirásková I, Klamová H, Lemez P, Rosa L.
    Neoplasma; 1998 May; 45(5):277-81. PubMed ID: 9921915
    [Abstract] [Full Text] [Related]

  • 10. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O, Zompi S, Perrot JY, Faussat AM, Benderra Z, Chaoui D, Marie JP.
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [Abstract] [Full Text] [Related]

  • 11. Phagocytosis in acute leukemia.
    Glasser L.
    Cancer; 1980 Mar 15; 45(6):1365-9. PubMed ID: 6153567
    [Abstract] [Full Text] [Related]

  • 12. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
    Namikawa R, Ueda R, Kyoizumi S.
    Blood; 1993 Oct 15; 82(8):2526-36. PubMed ID: 8104540
    [Abstract] [Full Text] [Related]

  • 13. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias.
    Cousar JB, Briggs RC.
    Leuk Res; 1990 Oct 15; 14(10):915-20. PubMed ID: 2259228
    [Abstract] [Full Text] [Related]

  • 14. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis.
    Su WP.
    Semin Dermatol; 1994 Sep 15; 13(3):223-30. PubMed ID: 7986692
    [Abstract] [Full Text] [Related]

  • 15. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
    Davey FR, Erber WN, Gatter KC, Mason DY.
    Am J Clin Pathol; 1988 Jan 15; 89(1):76-80. PubMed ID: 3422117
    [Abstract] [Full Text] [Related]

  • 16. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.
    Bijl JJ, van Oostveen JW, Walboomers JM, Brink AT, Vos W, Ossenkoppele GJ, Meijer CJ.
    Leukemia; 1998 Nov 15; 12(11):1724-32. PubMed ID: 9823947
    [Abstract] [Full Text] [Related]

  • 17. Expression of a monocyte-specific esterase isoenzyme in cases of acute myeloid leukemias.
    Drexler HG, Klein M, Bhoopalam N, Menon M, Messmore HL, Gaedicke G, Minowada J.
    Eur J Cancer Clin Oncol; 1985 Dec 15; 21(12):1485-91. PubMed ID: 3868620
    [Abstract] [Full Text] [Related]

  • 18. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA, Lin YC, Kuo YY, Chou WC, Lin CC, Liu CY, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.
    Ann Hematol; 2015 Feb 15; 94(2):211-21. PubMed ID: 25241285
    [Abstract] [Full Text] [Related]

  • 19. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG, Menon M, Gaedicke G, Minowada J.
    Cancer Immunol Immunother; 1986 Feb 15; 21(3):188-92. PubMed ID: 3457629
    [Abstract] [Full Text] [Related]

  • 20. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb 15; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.